{"url_path":"/sec/tgen/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1537435/0001537435-26-000038-index.html","accession_number":"0001537435-26-000038","cik":"0001537435","ticker":"TGEN","issuer_name":"TECOGEN INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1537435/0001537435-26-000038-index.html","primary_entity_key":"0001537435","primary_entity_name":"TECOGEN INC."},"word_count":83,"has_tables":true,"body_markdown":"Item 5. Other Information    \n\nSecurities Trading Plans of Directors and Executive Officers\n\nDuring the three months ended March 31, 2026, none of the Company’s directors or officers, as defined in Section 16 of the Securities Exchange Act, adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” as defined under Item 408(a) of Regulation S-K.\n\n30\n\nTECOGEN INC."}